Skip to main content

SpyGlass Pharma, Inc.

SGP
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001778922

No open-market purchases or sales by SpyGlass Pharma, Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $581.1M in total; no superinvestor holds it.

Superinvestors holding SGP, Q2 2026

See all superinvestors

No superinvestor reported holding SGP in Q2 2026.